Evidence map›Paper›PMID 35372895›Full record

Observational studyKidney3602020

Acute Peritoneal Dialysis During the COVID-19 Pandemic at Bellevue Hospital in New York City.

Nina J Caplin, Olga Zhdanova, Manish Tandon, Nathan Thompson, Dhwanil Patel, Qandeel Soomro, Fnu Ranjeeta, Leian Joseph, Jennifer Scherer, Shivam Joshi and 9 more

Open access · diamondAbstract readObservational Study
In one paragraph

Observational study in Kidney360, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.2field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Outcomes of PD for AKI treatment during COVID-19 in New York City: A multicenter study.Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis · 2023
    Observational
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 3 institutions in 2 countries.

Nina J CaplinDivision of Nephrology, New York University Langone Health and NYU Grossman School of Medicine, New York, New York.ORCID 0000-0002-3999-0967
Olga ZhdanovaDivision of Nephrology, New York University Langone Health and NYU Grossman School of Medicine, New York, New York.
Manish TandonDepartment of Surgery, NYU Langone Health and NYU Grossman School of Medicine, New York, New York.
Nathan ThompsonDivision of Nephrology, New York University Langone Health and NYU Grossman School of Medicine, New York, New York.
Dhwanil PatelDivision of Nephrology, New York University Langone Health and NYU Grossman School of Medicine, New York, New York.
Qandeel SoomroDivision of Nephrology, New York University Langone Health and NYU Grossman School of Medicine, New York, New York.
Fnu RanjeetaDivision of Nephrology, New York University Langone Health and NYU Grossman School of Medicine, New York, New York.
Leian JosephDivision of Nephrology, New York University Langone Health and NYU Grossman School of Medicine, New York, New York.
Jennifer SchererDivision of Nephrology, New York University Langone Health and NYU Grossman School of Medicine, New York, New York.
Shivam JoshiDivision of Nephrology, New York University Langone Health and NYU Grossman School of Medicine, New York, New York.
Betty DyalLower Manhattan Dialysis Center, Inc., New York, New York.
Harminder ChawlaDivision of Nephrology, New York University Langone Health and NYU Grossman School of Medicine, New York, New York.
Sitalakshmi IyerDivision of Nephrology, New York University Langone Health and NYU Grossman School of Medicine, New York, New York.
Douglas BailsDepartment of Medicine, New York City Health and Hospitals/Bellevue, New York, New York.
Judith BensteinDivision of Nephrology, New York University Langone Health and NYU Grossman School of Medicine, New York, New York.
David S GoldfarbDivision of Nephrology, New York University Langone Health and NYU Grossman School of Medicine, New York, New York.
Bruce GelbDivision of Nephrology, New York University Langone Health and NYU Grossman School of Medicine, New York, New York.
Richard AmerlingSt. George's University School of Medicine, True Blue Campus, St. Georges, Grenada.
David M CharytanDivision of Nephrology, New York University Langone Health and NYU Grossman School of Medicine, New York, New York.
New York University · USNew York City Health and Hospitals Corporation · USSt. George's University · GD

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The COVID-19 pandemic strained hospital resources in New York City, including those for providing dialysis. New York University Medical Center and affiliations, including New York City Health and Hospitals/Bellevue, developed a plan to offset the increased needs for KRT. We established acute peritoneal dialysis (PD) capability, as usual dialysis modalities were overwhelmed by COVID-19 AKI. Methods: Observational study of patients requiring KRT admitted to Bellevue Hospital during the COVID surge. Bellevue Hospital is one of the largest public hospitals in the United States, providing medical care to an underserved population. There were substantial staff, supplies, and equipment shortages. Adult patients admitted with AKI who required KRT were considered for PD. We rapidly established an acute PD program. A surgery team placed catheters at the bedside in the intensive care unit; a nephrology team delivered treatment. We provided an alternative to hemodialysis and continuous venovenous hemofiltration for treating patients in the intensive-care unit, demonstrating efficacy with outcomes comparable to standard care. Results: From April 8, 2020 to May 8, 2020, 39 catheters were placed into ten women and 29 men. By June 10, 39% of the patients started on PD recovered kidney function (average ages 56 years for men and 59.5 years for women); men and women who expired were an average 71.8 and 66.2 years old. No episodes of peritonitis were observed; there were nine incidents of minor leaking. Some patients were treated while ventilated in the prone position. Conclusions: Demand compelled us to utilize acute PD during the COVID-19 pandemic. Our experience is one of the largest recently reported in the United States of which we are aware. Acute PD provided lifesaving care to acutely ill patients when expanding current resources was impossible. Our experience may help other programs to avoid rationing dialysis treatments in health crises.

Indexed as

Acute Kidney InjuryCOVID-19Peritoneal DialysisAdultFemaleHospitalsHumansMaleMiddle AgedNew York CityPandemicsRenal DialysisSARS-CoV-2United Statesacute kidney injuryacute kidney injury and ICU nephrologycontinuous kidney replacement therapyCOVID-19hemodialysishospitalintensive care unitNew York Citypandemicperitoneal dialysisprone ventilation

Identifiers

PMID35372895
PMCPMC8815539
OpenAlexW3093446085

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.